Yael Silman-Steinberg
Tel Litwinsky, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The increasing role of abdominal metastesectomy for malignant melanoma in the era of modern therapeutics.
Journal: Surgical oncology
Published: February 28, 2022
Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma.
Journal: Cancers
Published: June 20, 2020
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.
Journal: Science (New York, N.Y.)
Published: March 06, 2020
Vemurafenib-induced DRESS/DIHS resulting in spontaneous melanoma regression: an immunological reaction shedding new light on melanoma treatment?
Journal: International journal of dermatology
Published: September 29, 2019
Isolated autoimmune adrenocorticotropic hormone deficiency: From a rare disease to the dominant cause of adrenal insufficiency related to check point inhibitors.
Journal: Autoimmunity reviews
Published: July 30, 2019
Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 08, 2018
Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors.
Journal: The oncologist
Published: June 17, 2018
Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600-mutant metastatic melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 22, 2018
Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case-Control Study.
Journal: Cancer immunology research
Published: November 16, 2017
Rheumatic manifestations among cancer patients treated with immune checkpoint inhibitors.
Journal: Autoimmunity reviews
Published: November 04, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026